Frazier Life Sciences Acquisition Corp. II

Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering

Frazier Life Sciences Acquisition Corp. II closed its $75 million IPO of 7.5 million Class A ordinary shares at $10.00 each, now trading on Nasdaq under ticker FLSC since October 14, 2026. The SPAC is sponsored by a Frazier Life Sciences affiliate and led by CEO Albert Cha, with Jefferies as sole book-runner; it will search for biotechnology-sector business combinations. This is a routine pre-deal SPAC listing with no operating business; watch for a future combination target before assigning fundamental relevance.

•10d ago